HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Fibrinogen Milano II: a congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis.

Abstract
A congenitally abnormal fibrinogen was isolated from blood of a young man with deep-vein thrombosis. Two other affected members of his family had three episodes of severe arterial thrombosis. The fibrinogen showed a delayed clotting by thrombin, but a normal clotting by Arvin, Reptilase, and prothrombin-staphylocoagulase complex. Analysis of the fibrinopeptides A and B by High Performance Liquid Chromatography did not reveal an abnormal peptide structure. The rate of release of A and B peptides by thrombin was strongly delayed, whereas the rate of release of fibrinopeptide A by Arvin appeared to be normal. The fibrin polymerization rate was normal. Interactions between the abnormal fibrinogen, platelets and the fibrinolytic system were also normal. Evidence is presented that the defective interaction between fibrinogen Milano II and thrombin is associated with a defective binding of thrombin to the fibrin moiety of the abnormal fibrinogen.
AuthorsF Haverkate, J Koopman, C Kluft, A D'Angelo, M Cattaneo, P M Mannucci
JournalThrombosis and haemostasis (Thromb Haemost) Vol. 55 Issue 1 Pg. 131-5 (Feb 28 1986) ISSN: 0340-6245 [Print] GERMANY, WEST
PMID3705000 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fibrinogens, Abnormal
  • fibrinogen Milano II
  • Fibrinopeptide A
  • Fibrinopeptide B
  • Fibrin
  • Fibrinogen
  • Thrombin
Topics
  • Adult
  • Blood Coagulation Disorders (complications, congenital, genetics)
  • Fibrin (metabolism)
  • Fibrinogen (isolation & purification)
  • Fibrinogens, Abnormal
  • Fibrinopeptide A (isolation & purification)
  • Fibrinopeptide B (isolation & purification)
  • Humans
  • Male
  • Pedigree
  • Platelet Aggregation
  • Thrombin (metabolism)
  • Thrombophlebitis (complications, genetics)
  • Thrombosis (complications, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: